We are recruiting overweight and obese participants with prediabetes or metformin-treated Type 2 Diabetes for a clinical research study investigating an investigational product in capsule, Gelesis200
Other safety areas under investigation include: Lean muscle mass preservation significant weight loss can result in loss of muscle tissue, and researchers are monitoring body composition changes Bone density a consideration with rapid weight loss in general Thyroid C-cell effects a class concern for GLP-1 receptor agonists, though clinical significance in humans remains uncertain [13] Pancreatitis and gallbladder disease signals observed across the incretin class are being monitored for retatrutide, though no established causal link has been confirmed for this agent specifically Dehydration and kidney function prolonged vomiting or diarrhoea can lead to dehydration and, in some cases, acute kidney injury
If you take a standard glutathione capsule, it has to travel through your digestive system
The SURMOUNT-5 trial published in the New England Journal of Medicine (2025) established tirzepatide as the most clinically impactful GLP-1 class therapy studied to date
This post covers the safety profile of combining these medications, how they may interact within your body, and the importance of clinical supervision during your treatment
Ivim Health GLP-1 Medication Options FAQ Spotlight: Is a specific medication or brand guaranteed on Ivim Health
